CompoundList
Sign in
Murcko scaffold

Ring system with 4 rings and 25 atoms

18 chemicals on CompoundList share this ring system.

Rings
4
Scaffold atoms
25
Chemicals
18
With full pages
4
Scaffold SMILES

c1ccc(COc2cncc(-c3cnn(C4CCNCC4)c3)c2)cc1

A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.

Substructure search with this scaffold
Murcko scaffold c1ccc(COc2cncc(-c3cnn(C4CCNCC4)c3)c2)cc1

Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.

Chemicals with this scaffold

Open one to see its structure, properties and suppliers.

Showing 1 to 18 of 18 chemicals

3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine chemical structure, C21H22Cl2FN5O, CAS 877400-66-3
3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
CAS 877400-66-3C21H22Cl2FN5O
Crizotinib chemical structure, C21H22Cl2FN5O, CAS 877399-52-5
Crizotinib
CAS 877399-52-5C21H22Cl2FN5O
3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(1-isopropylpiperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine chemical structure, C24H28Cl2FN5O, CAS 877400-79-8
3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(1-isopropylpiperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
CAS 877400-79-8C24H28Cl2FN5O
tert-Butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, (R)- chemical structure, C26H30Cl2FN5O3, CAS 877399-51-4
tert-Butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, (R)-
CAS 877399-51-4C26H30Cl2FN5O3
1,1-Dimethylethyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-1-d]-3-pyridinyl]-1H-pyrazol-1-yl]-1-piperidinecarboxylate chemical structure, C26H30Cl2FN5O3, CAS 1265484-29-4
1,1-Dimethylethyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-1-d]-3-pyridinyl]-1H-pyrazol-1-yl]-1-piperidinecarboxylate
CAS 1265484-29-4C26H30Cl2FN5O3
(S)-Crizotinib chemical structure, C21H22Cl2FN5O, CAS 1374356-45-2
(S)-Crizotinib
CAS 1374356-45-2C21H22Cl2FN5O
(S)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate chemical structure, C26H30Cl2FN5O3, CAS 877401-42-8
(S)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
CAS 877401-42-8C26H30Cl2FN5O3
Crizotinib acetate chemical structure, C23H26Cl2FN5O3, CAS 877399-53-6
Crizotinib acetate
CAS 877399-53-6C23H26Cl2FN5O3
Unecritinib chemical structure, C23H24Cl2FN5O2, CAS 1418026-92-2
Unecritinib
CAS 1418026-92-2C23H24Cl2FN5O2
Crizotinib impurity 59 chemical structure, C23H26Cl2FN5O, CAS 1428476-80-5
Crizotinib impurity 59
CAS 1428476-80-5C23H26Cl2FN5O
2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-, hydrochloride (1:1) chemical structure, C21H23Cl3FN5O, CAS 1415560-69-8
2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-, hydrochloride (1:1)
CAS 1415560-69-8C21H23Cl3FN5O
[3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine hydrochloride chemical structure, C21H23Cl3FN5O, CAS 877399-54-7
[3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine hydrochloride
CAS 877399-54-7C21H23Cl3FN5O
tert-Butyl 4-[4-[6-amino-5-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate chemical structure, C26H30Cl2FN5O3, CAS 1428476-86-1
tert-Butyl 4-[4-[6-amino-5-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate
CAS 1428476-86-1C26H30Cl2FN5O3
3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridine chemical structure, C21H21Cl2FN4O, CAS 2252256-73-6
3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridine
CAS 2252256-73-6C21H21Cl2FN4O
Crizotinib impurity 41 chemical structure, C21H23ClFN5O, CAS 1801651-84-2
Crizotinib impurity 41
CAS 1801651-84-2C21H23ClFN5O
Crizotinib-d5 chemical structure, C21H22Cl2FN5O, CAS 1395950-84-1
Crizotinib-d5
CAS 1395950-84-1C21H22Cl2FN5O
4-(3-(((2-Amino-5-(1-(1-(methyl-d3)piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-3-yl)oxy)methyl)phenyl)-2-methylbut-3-yn-2-ol chemical structure, C26H31N5O2, CAS 2768906-49-4
4-(3-(((2-Amino-5-(1-(1-(methyl-d3)piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-3-yl)oxy)methyl)phenyl)-2-methylbut-3-yn-2-ol
CAS 2768906-49-4C26H31N5O2
Crizotinib Impurity 63 .x p-Toluenesulfonic acid chemical structure, C33H38Cl2FN5O6S, CAS 2059996-30-2
Crizotinib Impurity 63 .x p-Toluenesulfonic acid
CAS 2059996-30-2C33H38Cl2FN5O6S